Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,573
Total Claims
$397K
Drug Cost
651
Beneficiaries
$610
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+38%
Opioid rate vs peers
63.3% vs 45.9% avg
+26%
Cost per patient vs peers
$610 vs $483 avg
+66%
Brand preference vs peers
6.8% vs 4.1% avg
Opioid Prescribing
63.3%
Opioid Rate
3,529
Opioid Claims
$274K
Opioid Cost
17.0%
Long-Acting Rate
This provider's opioid prescribing rate of 63.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 381 claims · $249K
Generic: 5,192 claims · $148K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 127 | $91K |
| Onabotulinumtoxina | 21 | $28K |
| Tapentadol Hcl | 13 | $26K |
| Oxycodone Hcl/Acetaminophen | 838 | $25K |
| Buprenorphine | 74 | $24K |
| Buprenorphine Hcl | 35 | $23K |
| Hydrocodone/Acetaminophen | 1,350 | $19K |
| Tapentadol Hcl | 27 | $18K |
| Rimegepant Sulfate | 11 | $12K |
| Naloxegol Oxalate | 23 | $9,708 |
| Fentanyl | 74 | $7,132 |
| Pregabalin | 335 | $6,871 |
| Morphine Sulfate | 214 | $6,848 |
| Gabapentin | 430 | $4,910 |
| Morphine Sulfate | 115 | $3,737 |
Prescribing Profile
36
Unique Drugs
12.0
Anomaly Score
Patient Profile
68
Avg Age
65%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data